[HTML][HTML] Lanreotide in metastatic enteropancreatic neuroendocrine tumors

…, G Cadiot, EM Wolin, J Capdevila, L Wall… - … England Journal of …, 2014 - Mass Medical Soc
Background Somatostatin analogues are commonly used to treat symptoms associated with
hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects …

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

…, M Finch-Jones, H Wasan, P Ross, L Wall… - The Lancet …, 2019 - thelancet.com
Background Despite improvements in multidisciplinary management, patients with biliary
tract cancer have a poor outcome. Only 20% of patients are eligible for surgical resection with …

[HTML][HTML] Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo …

…, R Sturgess, C Stubbs, DD Stocken, L Wall… - The lancet …, 2017 - thelancet.com
Background Transarterial chemoembolisation (TACE) is the standard of care for patients
with intermediate stage hepatocellular carcinoma, while the multikinase inhibitor sorafenib …

[HTML][HTML] Management of depression for people with cancer (SMaRT oncology 1): a randomised trial

V Strong, R Waters, C Hibberd, G Murray, L Wall… - The Lancet, 2008 - thelancet.com
Background Major depressive disorder severely impairs the quality of life of patients with
medical disorders such as cancer, but evidence to guide its management is scarce. We aimed …

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial

…, P Martin, S Symeonides, C Gourley, L Wall… - The Lancet, 2014 - thelancet.com
Background Medical conditions are often complicated by major depression, with consequent
additional impairment of quality of life. We aimed to compare the effectiveness of an …

[PDF][PDF] Better off dead: suicidal thoughts in cancer patients

…, DJ Storey, VA Strong, MT Fallon, LR Wall… - Journal of Clinical …, 2008 - researchgate.net
Purpose Cancer is associated with an increased risk of suicide and attempted suicide.
However, we do not know how many cancer patients have thoughts that they would be better off …

[HTML][HTML] Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

…, EM Wolin, J Capdevila, L Wall… - Endocrine-related …, 2016 - erc.bioscientifica.com
In the CLARINET study, lanreotide Autogel (depot in USA) significantly prolonged
progression-free survival (PFS) in patients with metastatic pancreatic/intestinal neuroendocrine …

Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.

…, P Corrie, S Falk, HS Wasan, PJ Ross, LR Wall… - 2017 - ascopubs.org
4006 Background: Despite improvements in multidisciplinary management, BTC has a poor
outcome. Approximately 20% of cases are suitable for surgical resection with a 5 year …

Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9‐item patient health questionnaire

…, I Butcher, L Hodges, A Kleiboer, M O'Connor, L Wall… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Systematic screening for depression has been recommended for patients
who have medical conditions like cancer. The 9‐item Patient Health Questionnaire (PHQ‐9) …

Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study

…, M Finch-Jones, H Wasan, P Ross, L Wall… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The BILCAP study described a modest benefit for capecitabine as adjuvant
therapy for curatively resected biliary tract cancer (BTC), and capecitabine has become the …